|
1
|
Bray F, Ren JS, Masuyer E and Ferlay J:
Global estimates of cancer prevalence for 27 sites in the adult
population in 2008. Int J Cancer. 132:1133–1145. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zur Hausen H: Papillomaviruses causing
cancer: Evasion from host-cell control in early events in
carcinogenesis. J Nat Cancer Inst. 92:690–698. 2009. View Article : Google Scholar
|
|
3
|
Bosch FX and de Sanjosé S: Chapter 1:
Human papillomavirus and cervical cancer-burden and assessment of
causality. J Nat Cancer Inst Monogr. 3–13. 2003. View Article : Google Scholar
|
|
4
|
Schlecht NF, Kulaga S, Robitaille J,
Ferreira S, Santos M, Miyamura RA, Duarte-Franco E, Rohan TE,
Ferenczy A, Villa LL and Franco EL: Persistent human papillomavirus
infection as a predictor of cervical intraepithelial neoplasia.
JAMA. 286:3106–3114. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
IARC Working Group on the Evaluation of
Carcinogenic Risks to Humans, . Human papillomaviruses. IARC Monogr
Eval Carcinog Risks Hum. 90:1–636. 2007.PubMed/NCBI
|
|
6
|
Muñoz N, Castellsagué X, de González AB
and Gissmann L: Chapter 1: HPV in the etiology of human cancer.
Vaccine. 24:(Suppl 3). S3/1–10. 2006. View Article : Google Scholar
|
|
7
|
Castellsagué X, Díaz M, de Sanjosé S,
Muñoz N, Herrero R, Franceschi S, Peeling RW, Ashley R, Smith JS,
Snijders PJ, et al: Worldwide human papillomavirus etiology of
cervical adenocarcinoma and its cofactors: Implications for
screening and prevention. J Natl Cancer Inst. 98:303–315. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Catle PE and Giuliano AR: Chapter 4:
Genital tract infections, cervical inflammation, and antioxidant
nutrients assessing their roles as human papillomavirus cofactors.
J Natl Cancer Inst Monogr. 31:29–34. 2003. View Article : Google Scholar
|
|
9
|
Moscicki AB, Schiffman M, Kjaer S and
Villa LL: Chapter 5: Updating the natural history of HPV and
anogenital cancer. Vaccine. 24:(Suppl) S3/42–51. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cuschieri KS, Cuble HA, Whitley MW,
Gilkison G, Arends MJ, Graham C and McGoogan E: Persistent high
risk HPV infection associated with development of cervical
neoplasia in a prospective population study. J Clin Pathol.
58:946–950. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cedet J, Delatour T, Douki T, Gasparutto
D, Pouget JP, Ravanat JL and Sauvaigo S: Hydroxyl radicals and DNA
base damage. Mutat Res. 424:9–21. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zou C, Liu H, Feugang JM, Hao Z, Chow HH
and Garcia F: Green tea compound in chemoprevention of cervical
cancer. Int J Gynecol Cancer. 20:617–624. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bjelakovic G, Nikolova D, Simonetti RG and
Gluud C: Antioxidant supplements for prevention gastrointestinal
cancers: A systematic review and meta-analysis. Lancet.
364:1219–1228. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Di Domenico F, Foppoli C, Coccia R and
Perluigi M: Antioxidants in cervical cancer: Chemopreventive and
chemotherapeutic effects of polyphenols. Biochim Biophys Acta.
1822:737–747. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Siegel EM, Salemi JL, Villa LL, Ferenczy
A, Franco AL and Giuliano AR: Dietary consumption of antioxidant
nutrients and risk of incident cervical intraepithelial neoplasia.
Gynecol Oncol. 118:289–294. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Busby JE and Kamat AM: Chemoprevention for
bladder cancer. J Urol. 176:1914–1920. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thapa D and Ghosh R: Antioxidants for
prostate cancer chemoprevention: Challenges and opportunities.
Biochem Pharmacol. 83:1319–1330. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF,
Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, et al: Phase I
clinical trial of curcumin, a chemopreventive agent, in patients
with high-risk or pre-malignant lesions. Anticancer Res.
21:2895–2900. 2001.PubMed/NCBI
|
|
19
|
Ahn WS, Huh SW, Bae SM, Lee IP, Lee JM,
Namkoong SE, Kim CK and Sin JI: A major constituent of green tea,
EGCG, inhibits the growth of a human cervical cell line, Caski
cells, through apoptosis, G(1) arrest, and regulation of gene
expression. DNA Cell Biol. 22:217–224. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
García-Closas R, Castellsagué X, Bosch X
and González CA: The role of diet and nutrition in cervical
carcinogenesis: A review of recent evidence. Int J Cancer.
117:629–637. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Goodman M, Bostick RM, Kucuk O and Jones
DP: Clinical trials of antioxidants as cancer prevention agents:
Past, present, and future. Free Radic Biol Med. 51:1068–1084. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Narayanan BA, Geoffroy O, Willingham MC,
Re GG and Nixon DW: p53/p21 (WAF1/CIP1) expression and its possible
role in G1 arrest and apoptosis in ellagic acid treated cancer
cells. Cancer Lett. 136:215–221. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tomita LY, Filho A Longatto, Costa MC,
Andreoli MA, Villa LL, Franco EL and Cardoso MA: Brazilian
Investigation into Nutrition and Cervical Cancer Prevention
(BRINCA) Study Team: Diet and serum micronutrients in relation to
cervical neoplasia and cancer among low-income Braazilian women.
Int J Cancer. 126:703–714. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Häkkinen S, Heinonen M, Kärenlampi S,
Mykkänen H, Ruuskanen J and Törrönen R: Screening of selected
flavonoids and phenolic acids in 19 berries. Food Res Int.
32:345–353. 1999. View Article : Google Scholar
|
|
25
|
Moghadamtousi SZ, Fadaeinasab M, Nikzad S,
Mohan G, Ali HM and Kadir HA: Annona Muricata (Annonaceae): A
review of its traditional uses, isolated acetogenins and biological
activities. Int J Mol Sci. 16:15625–15658. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Solomon D, Davey D, Kurman R, Moriarty A,
O'Connor D, Prey M, Raab S, Sherman M, Wilbur D and Wright T Jr:
The 2001 Bethesda System: Terminology for reporting results of
cervical cytology. JAMA. 287:2114–2119. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
De Marco F: Oxidative stress and HPV
carcinogenesis. Viruses. 5:708–731. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
De Marco F, Bucaj E, Foppoli C, Fiorini A,
Blarzino C, Filipi K, Giorgi A, Schininà ME, Di Domenico F, Coccia
R, et al: Oxidative stress in HPV-driven viral carcinogenesis:
Redox proteomics analysis of HPV-16 dyspalstic and neoplastic
tissues. PLoS One. 7:e343662012. View Article : Google Scholar : PubMed/NCBI
|
